Metformin reduces total microparticles and microparticles-expressing tissue factor in women with polycystic ovary syndrome

No abstract is available for this paper.

• Publication year

  2017

• Venue

  Archives of Gynecology and Obstetrics

• Publication date

  2017-08-09

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s00404-017-4471-0PMID 28795250
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Microparticles: Inflammatory and haemostatic biomarkers in Polycystic Ovary Syndrome.

  2017cited by this paper
• Cross Talk Pathways Between Coagulation and Inflammation.

  2016cited by this paper
• Effect of colchicine on polycystic ovary syndrome: an experimental study

  2016cited by this paper
• Procoagulant microparticles promote coagulation in a factor XI‐dependent manner in human endotoxemia

  2016cited by this paper
• Microvesicles and exosomes: new players in metabolic and cardiovascular disease.

  2016cited by this paper
• Microparticle analysis in disorders of hemostasis and thrombosis

  2016cited by this paper
• Polycystic ovary syndrome (PCOS) and hyperandrogenism: the role of a new natural association.

  2015cited by this paper
• Metformin suppresses intrahepatic coagulation activation in mice with lipopolysaccharide/D‑galactosamine‑induced fulminant hepatitis.

  2015cited by this paper
• Clinical significance of procoagulant microparticles

  2015cited by this paper
• Increased thrombin generation in women with polycystic ovary syndrome: A pilot study on the effect of metformin and oral contraceptives.

  2015cited by this paper
• Metformin reduces hyper-reactivity of platelets from patients with polycystic ovary syndrome by improving mitochondrial integrity

  2015cited by this paper
• Metformin in women with PCOS, Pros

  2015cited by this paper
• Clinical Significance of Tissue Factor–Exposing Microparticles in Arterial and Venous Thrombosis

  2015cited by this paper
• Tissue‐factor‐bearing microparticles (MPs‐TF) in patients with acute ischaemic stroke: the influence of stroke treatment on MPs‐TF generation

  2015cited by this paper
• Metformin in women with PCOS, CONS

  2015cited by this paper
• Young women with polycystic ovary syndrome have raised levels of circulating annexin V-positive platelet microparticles.

  2014cited by this paper
• Long‐term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial

  2014cited by this paper
• Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria

  2014cited by this paper
• Metformin: an old but still the best treatment for type 2 diabetes

  2013cited by this paper
• Platelet-derived microparticles in overweight/obese women with the polycystic ovary syndrome

  2013cited by this paper
• Efficacy of combined metformin–letrozole in comparison with bilateral ovarian drilling in clomiphene-resistant infertile women with polycystic ovarian syndrome

  2013cited by this paper
• Haemostatic Effects of Metformin in Simvastatin‐Treated Volunteers with Impaired Fasting Glucose

  2012cited by this paper
• Hormone replacement therapy leads to increased plasma levels of platelet derived microparticles in postmenopausal women

  2012cited by this paper
• Circulating platelet-derived microparticles are elevated in women with polycystic ovary syndrome diagnosed with the 1990 criteria and correlate with serum testosterone levels.

  2011cited by this paper
• [Effects of metformin therapy on markers of coagulation disorders in hyperinsulinemic women with polycystic ovary syndrome].

  2011cited by this paper
• Augmented plasma microparticles during acute Plasmodium vivax infection

  2010cited by this paper
• Comparison of four different treatment regimens on coagulation parameters, hormonal and metabolic changes in women with polycystic ovary syndrome

  2009cited by this paper
• Tumor-Derived Tissue FactorBearing Microparticles Are Associated With Venous Thromboembolic Events in Malignancy

  2009cited by this paper
• Polycystic Ovarian Syndrome and the Risk of Cardiovascular Disease and Thrombosis

  2009cited by this paper
• Tissue-factor-bearing microvesicles arise from lipid rafts and fuse with activated platelets to initiate coagulation.

  2005cited by this paper
• Elevated levels of VE-cadherin-positive endothelial microparticles in patients with type 2 diabetes mellitus and coronary artery disease.

  2005cited by this paper
• Elevation of endothelial microparticles, platelets, and leukocyte activation in patients with venous thromboembolism.

  2005cited by this paper
• Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS).

  2004cited by this paper
• Beneficial effects of metformin on haemostasis and vascular function in man.

  2003influential reference
• International Journal of Women's Health Dovepress Complications and Challenges Associated with Polycystic Ovary Syndrome: Current Perspectives

  year unknowncited by this paper

• Circulating Microparticles as Indicators of Cardiometabolic Risk in PCOS.

  2022cites this paper
• Expression of tissue factor and tissue factor pathway inhibitors during ovulation in rats: a relevance to the ovarian hyperstimulation syndrome

  2021cites this paper
• Polycystic ovary syndrome: clinical and laboratory variables related to new phenotypes using machine-learning models

  2021cites this paper
• Expression of Tissue Factor and Tissue Factor Pathway Inhibitors during Ovulation in Rats: A Potential Biomarker for Ovarian Hyperstimulation Syndrome

  2021cites this paper
• Extracellular Vesicles: Recent Developments in Aging and Reproductive Diseases

  2020influential citation
• The effects of empagliflozin vs metformin on endothelial microparticles in overweight/obese women with polycystic ovary syndrome

  2020cites this paper
• Metformin Is Associated with Reduced Tissue Factor Procoagulant Activity in Patients with Poorly Controlled Diabetes

  2020cites this paper
• Exosomes and Female Infertility.

  2019cites this paper
• Benign Diseases of the Ovary

  2019cites this paper
• Novel interventional therapies to improve cardiovascular risk in women with polycystic ovary syndrome

  2018cites this paper
• Polycystic Ovary Syndrome as a systemic disease with multiple molecular pathways: a narrative review

  2018influential citation